Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products — Content and Format
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 12, 2023
January 13, 2023
e2343785-81a2-4852-aba8-7ffd3a086deb
Related Documents
Labeling for Biosimilar and Interchangeable Biosimilar Products
Guidance DocumentSeptember 18, 2023Center for Drug Evaluation and Research
Geriatric Information in Human Prescription Drug and Biological Product Labeling Guidance for Industry: Draft Guidance for Industry
Guidance DocumentSeptember 15, 2020Center for Drug Evaluation and Research
Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry
Guidance DocumentJuly 6, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox